Mario R. Mautino

Mario R. Mautino is a senior R&D executive and scientist with diverse experience in drug discovery and development, including strategic planning, program management and intellectual property management. Mario brings more than 25 years of experience in the fields of gene therapy, immuno-oncology, immunology, R&D and drug and pharmaceutical development.

Mario has led multiple research projects related to design of vaccines, small molecule drug discovery and research of combinations of therapeutic modalities in different cancer models including chemotherapy, vaccination, inhibition of metabolic and other immune checkpoints. Mario spent most of his professional career at NewLink Genetics Corporation as senior vice president of R&D. At present, Mario is a founding member and Chief Scientific Officer at Syncromune, a biopharmaceutical company developing intra-tumoral immuno-oncology therapeutic treatments.

Mario obtained his Ph.D at the University of Córdoba in Argentina, followed by a post-doctoral training at the Clinical Gene Therapy Branch at the National Institutes of Health.